Pricing Log in Create free account

MBody AI Ltd. (MBAI) vs Exagen Inc. (XGN)

MBody AI Ltd. and Exagen Inc. are both Diagnostics & Research companies. Exagen Inc. is the larger, with a market value of $207.4M against $47.4M — 4.4× the size. MBody AI Ltd. has the higher net margin (0.00% vs −26.6%) and the higher return on invested capital (0.00% vs −68.3%). Across the 14 metrics below, MBody AI Ltd. leads on 10 and Exagen Inc. on 4.

Valuation

Metric MBAI XGN Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 2.60 4.37
P/B 0.61 15.13 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales n/m 2.60 5.51
Earnings yield (763.41%) (10.59%) (1.89%)
Free cash flow yield (565.34%) (4.10%) (0.15%)

Profitability

Metric MBAI XGN Diagnostics & Research median
Gross margin 0.00% 58.64% 50.89%
Operating margin 0.00% (18.58%) (8.57%)
Net margin 0.00% (26.61%) (6.37%)
Free cash flow margin 0.00% (10.66%) 0.00%
Return on equity 0.00% (113.82%) (2.92%)
Return on assets 0.00% (34.19%) (6.71%)
Return on invested capital 0.00% (68.33%) 0.00%

Growth

Metric MBAI XGN Diagnostics & Research median
Revenue growth (TTM) — 20.83% 7.69%
EPS growth (last fiscal year) 115.35% (12.05%) 25.92%
Revenue growth, 5-year CAGR — 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI XGN Diagnostics & Research median
Debt to equity 0.00 2.00 0.11
Current ratio 0.71 3.18 2.02
Net debt to EBITDA 0.09 0.68 0.70

Dividend

Metric MBAI XGN Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MBAI XGN Diagnostics & Research median
Market cap 47.41m 207.37m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack